Testing effectiveness (Phase 2)Looking for participantsNCT07495215
What this trial is testing
A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection
Who this might be right for
Hepatocellular Carcinoma (HCC)
Yinghua Xu 20